Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2021 08:00 ET | Source: Olink Proteomics AB

Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure

UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of...
December 02, 2021 08:00 ET | Source: Olink Proteomics AB

Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure

UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of...
December 01, 2021 08:00 ET | Source: Olink Proteomics AB

Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery

UPPSALA, Sweden, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the delivery of Olink® Explore 3072 is now starting, providing customers with access to...
December 01, 2021 08:00 ET | Source: Olink Proteomics AB

Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery

UPPSALA, Sweden, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the delivery of Olink® Explore 3072 is now starting, providing customers with access to...
November 29, 2021 09:00 ET | Source: Olink Proteomics AB

Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France

UPPSALA, Sweden, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the winner of the young researchers’ award, Novelties in Biomarkers, Melissa Amrein at...
November 29, 2021 09:00 ET | Source: Olink Proteomics AB

Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France

UPPSALA, Sweden, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the winner of the young researchers’ award, Novelties in Biomarkers, Melissa Amrein at...
November 23, 2021 08:00 ET | Source: Olink Proteomics AB

Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform

UPPSALA, Sweden, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery of Olink® Signature Q100, facilitating hands-on access...
November 23, 2021 08:00 ET | Source: Olink Proteomics AB

Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform

UPPSALA, Sweden, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery of Olink® Signature Q100, facilitating hands-on access...
November 11, 2021 08:00 ET | Source: Olink Proteomics AB

Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies

ROCKVILLE, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited...
November 11, 2021 08:00 ET | Source: Olink Proteomics AB

Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies

ROCKVILLE, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited...